β-blocker binding to human 5-HT(1A) receptors in vivo and in vitroImplications for antidepressant therapy

Neuropsychopharmacology

Volumn 23, Issue 3, 2000, Pages 285-293

  Rabiner, Eugenii A ^a,b,c   Gunn, Roger N ^a   Castro, M Elena ^b,d   Sargent, Peter A ^a,b   Cowen, Philip J ^b   Koepp, Matthias J ^a   Meyer, Jeffrey H ^e   Bench, Christopher J ^a,c   Harrison, Paul J ^b   Pazos, Angel ^d   Sharp, Trevor ^b   Grasby, Paul M ^a,c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antidepressant drugs; Autoradiography; Human 5 HT(1A) receptor; Pindolol; Positron emission tomography

Indexed keywords

ANTIDEPRESSANT AGENT; AUTORECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON 11; LEVOTOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PENBUTOLOL; PINDOLOL; POSTSYNAPTIC RECEPTOR; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; TERTATOLOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; BRAIN SLICE; CONTROLLED STUDY; DEPRESSION; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY; VOLUNTEER;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANTIDEPRESSIVE AGENTS; AUTORADIOGRAPHY; AUTORECEPTORS; BRAIN CHEMISTRY; FEMALE; HUMANS; MALE; MIDDLE AGED; PENBUTOLOL; PINDOLOL; PIPERAZINES; PROPANOLAMINES; PYRIDINES; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS; THIOPHENES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034284859     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00109-3     Document Type: Article

References (56)

1. Adell A, Artigas F (1991): Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. Naunyn-Schmiedebergs Arch Pharmacol 343:237-244
2. Anderson I (1997): Lessons to be learnt from meta-analyses of newer versus older antidepressants. Advances in Psychiatric Treatment 3:58-63
3. Anderson I, Cowen P (1992): Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers. Psychopharmacology 106:428-432
4. Andree B, Thorberg S, Halldin C, Farde L (1999): Pindolol binding to 5-HT1A receptors confirmed with positron emission tomography. Psychopharmacology 144:303-305
5. Artigas F (1993): 5-HT and antidepressants: New views from microdialysis studies. Trends Pharmacol Sci 14:262
6. Artigas F, Perez V, Gilaberte I, Hervas I, Romero L, Casanovas J, Alvarez E (1997): Effects of selective and non-selective 5-HT1A antagonists on the presynaptic serotonergic function during antidepressant treatments. Abstracts of the 36th Annual Meeting of the American College of Neuropsychopharmacology, Kamuela, Hawaii, pp 36
7. Berman R, Darnell A, Miller H, Anand A, Charney D (1997): Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: A double-blind, placebo-controlled trial. Am J Psychiatry 154:37-43
8. Blier P, de Montigny C, Chaput Y (1990): Modifications of the serotonergic system by antidepressant treatments: Implications for the therapeutic response in major depression. J Clin Psychopharmacol 7:24S-35S
9. Bordet R, Thomas P, Dupuis B (1998): Effect of pindolol on onset of action of paroxetine in the treatment of major depression: Intermediate analysis of a double-blind, placebo-controlled trial. Am J Psychiatry 155:1346-1351
10. Campbell D, Chignon J, Devissaguet J (1986): Biodisposition of tertatolol in man: A review. Am J Nephrol 6 suppl 2:61-68
11. Chaput Y, de Montigny C, Blier P (1991): Presynaptic and postsynaptic modifications of the serotonin system by long-term antidepressant treatments: Electrophysiological studies in the rat brain. Neuropsychopharmacology 5:219-229
12. Chaput Y, de Montigny C, Blier P (1986): Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain. Naunyn-Schmiedebergs Arch Pharmacol 333:342-348
13. Clifford E, Gartside S, Umbers V, Cowen P, Hajos M, Sharp T (1998): Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo. Br J Pharmacol 124:206-212
14. Cunningham V, Lammertsma A (1994): Radioligand studies in brain: Kinetic analysis of PET data. Med Chem Res 5:79-96
15. de Montigny C, Blier P, Chaput Y (1990): Electrophysiological investigation of the effects of antidepressant treatments on serotonin receptors. In Vanhoutte P, Paoletti R, Brunello N, Maggi F (eds), Serotonin: From Cell Biology to Pharmacology and Therapeutics. Dordrecht, Kluwer Academic Publishers, pp 499-504
16. Dollery C (1999): Therapeutic Drugs, 2 Ed. New York, Churchill Livingstone
17. Fristen K, Frith C, Liddle P, Frackowiak R (1991): Plastic transformation of PET images. J Comp Assist Tomography 15:634-639
18. Gartside S, Clifford E, Cowen P, Sharp T (1999): Effects of (-)-tertatolol, (-)-penbutolol, and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: An in vivo microdialysis and electrophysiological study. Br J Pharmacol 127:145-152
19. Grootoonk S, Spinks T, Sashin D, Spyrou N, Jones T (1996): Correction for scatter in 3D brain PET using a dual energy window method. Phys Med Biol 41:2757-2774
20. Gunn R, Hume S, Hirani E, Khan I, Opacka-Juffry J (1999): Small animal PET enables parametric mapping of saturation kinetics at the 5-HT1A receptor. J Cereb Blood Flow Metab 19:761
21. Gunn R, Lammertsma A, Hume S, Cunningham V (1997): Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6:279-287
22. 11C]WAY-100635 for PET. Neuroimage 8:426-440
23. 11C]WAY-100635. Brain Res 745:96-108
24. Hirani E, Opacka-Juffry J, Gunn R, Khan I, Sharp T, Hume S (1999): Pindolol Occupancy of 5-HT1A Receptors Measured in Vivo Using Small Animal Positron Emission Tomography with Carbon-11 Labelled WAY 100635. Submitted to Synapse
25. Hjorth S (1993): Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor Citalopram to increase nerve terminal output of 5-HT in vivo: A microdialysis study. J Neurochem 60:776-779
26. Hjorth S, Auerbach S (1994): Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur J Pharmacol 260:251-255
27. Hjorth S, Carlsson A (1986): Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? Eur J Pharmacol 129:131-138
28. Hjorth S, Sharp T (1993): In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta-adrenoceptor antagonist (-)-penbutolol. J Pharmacol Exp Ther 265:707-712
29. Invernizzi R, Belli S, Samanin R (1992): Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res 584:322-324
30. Invernizzi R, Carli M, DiClimente A, Samanin R (1991): Administration of 8-hydroxy-2-(di-n-propylamino) tetralin in raphe nuclei dorsalis and medialis reduces serotonin synthesis in the rat brain: Differences in potency and regional sensitivity. J Neurochem 56:243-247
31. 1A receptors in the rat brain. Naunyn-Schmiedebergs Arch Pharmacol 347:453-463
32. 1A receptor antagonist. Brain Res 673:217-225
33. Lammertsma A, Hume S (1996): Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158
34. Maes M, Vandoolaeghe E, Desnyder R (1996): Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression. J Affect Disord 41:201-210
35. 11C]WAY-100635, via 11C-carboxylation of an immobilized Gringard reagent. Journal of Labelled Compounds and Radiopharmaceuticals 38:941-953
36. Meyer J, Gunn R, Myers R, Grasby P (1999): Assessment of spatial normalisation of PET ligand images using ligand specific templates. Neuroimage 9:545-553
37. Moreno F, Gelenberg A, Bachar K, Delgado P (1997): Pindolol augmentation of treatment resistant depression. J Clin Psych 58:437-439
38. 1A) receptors. Neuropsychopharmacology 18:395-398
39. Paykel E, Priest P (1992): Recognition and management of depression in general practice; consensus statement. BMJ 305:1198-1202
40. Pazos A, Hoyer D, Dietl M, Palacios J (1988): Autoradiography of serotonin receptors. In: Osborne N, Hamon M (eds) Neuronal Serotonin. John Wiley & Sons Ltd, Chichister, pp 507-543
41. Perez V, Gilaberte I, Faries D, Alvarez E, Artigas F (1997): Randomised, double blind, placebo controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 349:1594-1597
42. Perez V, Soler J, Puigdemont D, Alvarez E, Artigas F (1999): A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Archives Gen Psychiatry 56:375-379
43. 1B binding sites in bovine brain. Brain Res 344:167-171
44. Prisco S, Cagnotto A, Talone D, Blasi AD, Mennini T, Esposito E (1993): Tertatolol, a new β-blocker, is a serotonin (5-hydroxytryptamine1A) receptor antagonist in rat brain. J Pharmacol Exp Therap 265:739-744
45. 1A receptors in man using PET. Int J Neuropsychopharmacol 1: S65-S66
46. 1A receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain. Synapse 34:68-76
47. Romero L, Bel N, Artigas F, de Montigny C, Blier P (1996): Effect of pindolol on the function of pre- and postsynaptic 5HT1a receptors: In vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 15:349-360
48. Rowland M, Tozer T (1980): Clinical Pharmacokinetics: Concepts and Applications. Lea & Febiger, Lea & Febiger
49. Rudorfer M, Potter W (1989): Antidepressants: A comparative review of the clinical pharmacology and therapeutic use of the "newer" versus the "older" drugs. Drugs 37:713-738
50. Seletti B, Benkelfat C, Blier P, Annable L, Gilbert F, de Montigny C (1995): Serotonin 1A receptor activation by flesinoxan in humans. Neuropsychopharmacology 13:94-104
51. Sharp T, Bramwell S, Graham-Smith D (1989): 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 96:283-290
52. Sinton C, Fallon S (1988): Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. Eur J Pharmacol 157:173-181
53. Spinks T, Jones T, Bailey D, Townsend D, Grootoonk S, Bloomfield P, Gilardi M-C, Casey M, Sipe B, Reed J (1992): Physical performance of a positron tomograph for brain imaging with retractable septa. Phys Med Biol 37:1637-1655
54. Tome M, Isaac M, Harte R, Holland C (1997): Paroxetine and pindolol: A randomised trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. Int Clin Psychopharmacol 12:81-89
55. Vandermaelen C, Matheson G, Wilderman R, Patterson L (1986): Inhibition of serotonergic dorsal raphe neurones by systemic and ionophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur J Pharmacol 129:123-130
56. Zanardi R, Artigas F, Franchini L, Sforzini L, Gasperini M, Smeraldi E, Perez J (1997): How long should pindolol be associated with paroxetine to improve the antidepressant response? J Clin Psychopharmacol 17:446-450